B46.2
Gastrointestinal mucormycosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Gastrointestinal mucormycosis is a rare but serious fungal infection that affects the digestive system. Caused by a group of molds known as Mucorales, this condition can lead to severe complications if not diagnosed and treated promptly. It primarily occurs in individuals with weakened immune systems, such as those undergoing chemotherapy, organ transplant recipients, or people with uncontrolled diabetes. Awareness of this condition can help in early recognition and effective management.
Causes & Symptoms
Clinical Causes: Inhalation of Mucorales spores followed by ingestion Compromised immune system due to conditions like leukemia, lymphoma, or HIV/AIDS Uncontrolled diabetes, especially with ketoacidosis Prolonged use of corticosteroids or immunosuppressive medications Malnutrition and poor general health Use of contaminated food or medicine
Key Symptoms: Abdominal pain or cramping Nausea and vomiting, sometimes with blood Gastrointestinal bleeding Diarrhea or constipation Fever and general malaise Unintended weight loss Signs of intestinal obstruction or perforation in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing gastrointestinal mucormycosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Healthcare providers may use endoscopy to visualize the affected areas of the gastrointestinal tract and take tissue biopsies. Microscopical examination of these samples can reveal the characteristic fungal hyphae. Additionally, culture and histopathological analysis help confirm the presence of Mucorales fungi. Imaging studies like CT scans may assist in assessing the extent of tissue damage and complications such as perforation or abscess formation.
Treatment Protocols: Treatment of gastrointestinal mucormycosis typically involves a combination of antifungal medications and surgical intervention. Amphotericin B is often the first-line antifungal used to combat the infection. In some cases, debriding or removing damaged tissues surgically is necessary, especially if there are complications like perforation or abscesses. Managing underlying conditions, such as controlling blood sugar levels in diabetics, is crucial to improve outcomes. Supportive care, including nutritional support and addressing any additional infections or complications, plays an important role in recovery.
Clinical Advice & FAQs
Billing Guidance
Is B46.2 a billable ICD-10 code?
Yes, B46.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B46.2?
Clinical documentation must specify the nature of Gastrointestinal mucormycosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference